Mathews; Neil

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mathews; Neil.The latest application filed is for "spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (rsv)".

Company Profile

0.6.14

Mathews; Neil - Stevenage GB
Mathews; Neil - London GB
Mathews; Neil - Cardiff GB
Mathews; Neil - Welwyn GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (RSV) Grant 10,106,539 - Cockerill , et al. October 23, 2	2018-10-23
Pharmaceutical compounds Grant 9,809,575 - Cockerill , et al. November 7, 2	2017-11-07
Spiro-indolines For The Treatment And Prophylaxis Of Respiratory Syncytial Virus Infection (rsv) App 20170305908 - Cockerill; Stuart ; et al.	2017-10-26
Pharmaceutical Compounds App 20140308282 - Cockerill; Stuart ; et al.	2014-10-16
Biphenyl derivatives and their use in treating hepatitis C Grant 8,008,303 - Wheelhouse , et al. August 30, 2	2011-08-30
Novel Compounds - 644 App 20100215618 - Carter; Malcolm Clive ; et al.	2010-08-26
Triazoloanilinopyrimidine Derivatives For Use As Antiviral Agents App 20100158863 - Mathews; Neil ; et al.	2010-06-24
Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents App 20080311076 - Spencer; Keith Charles ; et al.	2008-12-18
Chemical Compounds App 20080267914 - Barnes; Michael Christopher ; et al.	2008-10-30
Biphenyl Derivatives and Their Use in Treating Hepatitis C App 20080255105 - Wheelhouse; Christopher James ; et al.	2008-10-16
Quinazoline Derivatives as Antiviral Agents App 20080114008 - Cockerill; George Stuart ; et al.	2008-05-15
2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase, 2 (COX-2) inhibitors App 20050113377 - Beswick, Paul John ; et al.	2005-05-26
2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors Grant 6,831,097 - Beswick , et al. December 14, 2	2004-12-14
Process for the preparation of pyrazolopyridine derivatives Grant 6,803,463 - Mathews , et al. October 12, 2	2004-10-12
2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors App 20040063745 - Gellibert, Francoise Jeanne ; et al.	2004-04-01
Compounds App 20040063949 - Gellibert, Francoise Jeanne ; et al.	2004-04-01
Process for the preparation of pyrazolopyridine derivatives App 20030078267 - Mathews, Neil ; et al.	2003-04-24
2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibirors App 20030040517 - Beswick, Paul John ; et al.	2003-02-27
2,3-Diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors App 20030008872 - Beswick, Paul John ; et al.	2003-01-09
2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors Grant 6,451,794 - Beswick , et al. September 17, 2	2002-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.